CBD Life Sciences Inc. (OTCMKTS:CBDL – Get Free Report) saw a large growth in short interest in the month of May. As of May 29th, there was short interest totaling 246,664 shares, a growth of ? from the May 14th total of 0 shares. Based on an average daily trading volume, of 11,136,168 shares, the days-to-cover ratio is presently 0.0 days.
CBD Life Sciences Stock Performance
Shares of CBDL opened at $0.00 on Monday. CBD Life Sciences has a 1 year low of $0.00 and a 1 year high of $0.00.
CBD Life Sciences Company Profile
CBD Life Sciences, Inc is a U.S.-based company focused on developing and commercializing cannabinoid?enhanced products for the wellness and consumer healthcare markets. The company’s core strategy centers on leveraging plant-derived phytocannabinoids, along with complementary natural ingredients, to formulate a range of topical and ingestible offerings. CBD Life Sciences operates under an emerging?brand model, seeking to position its products at the intersection of pharmaceutical?grade quality and mainstream consumer appeal.
The company’s product portfolio includes broad?spectrum hemp-derived topical creams, gels and balms designed for localized relief, as well as oral formulations such as capsules, tinctures and soft gels aimed at general wellness support.
Featured Stories
- Five stocks we like better than CBD Life Sciences
- 3 ETFs Giving Ready-Made Access to the Discounted International Small-Cap Space
- What to Expect From Q2 Earnings as Tech Strength Broadens
- Viasat’s Orbiting Profits: Space Force Jackpot?
- Robinhood Wants a Bigger Role in IPOs—Here’s Why It Matters
Receive News & Ratings for CBD Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CBD Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
